Impact of the early COVID‐19 pandemic on adult mental health‐related dispensed medications, hospitalizations and specialist outpatient visits in Norway and Sweden: Interrupted time series analysis
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16044 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von David Moreno-Martos und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Population Health and Genomics, University of Dundee, Dundee, UK. Hauptthemen laut MEDLINE: COVID-19, Interrupted Time Series Analysis, Hospitalization, Mental Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NordForsk, Norges Forskningsråd, Swedish state.
Abstract (Originalsprache)
Aims
Norway and Sweden had different early pandemic responses that may have impacted mental health management. The aim was to assess the impact of the early COVID‐19 pandemic on mental health‐related care.
Methods
We used national registries in Norway and Sweden (1 January 2018–31 December 2020) to define 2 cohorts: (i) general adult population; and (ii) mental health adult population. Interrupted times series regression analyses evaluated step and slope changes compared to prepandemic levels for monthly rates of medications (antidepressants, antipsychotics, anxiolytics, hypnotics/sedatives, lithium, opioid analgesics, psychostimulants), hospitalizations (for anxiety, bipolar, depressive/mood, eating and schizophrenia/delusional disorders) and specialist outpatient visits.
Results
In Norway, immediate reductions occurred in the general population for medications (−12% antidepressants to −7% hypnotics/sedatives) except for antipsychotics; and hospitalizations (−33% anxiety disorders to −17% bipolar disorders). Increasing slope change occurred for all medications except psychostimulants (+1.1%/month hypnotics/sedatives to +1.7%/month antidepressants); and hospitalization for anxiety disorders (+5.5%/month), depressive/mood disorders (+1.7%/month) and schizophrenia/delusional disorders (+2%/month). In Sweden, immediate reductions occurred for antidepressants (−7%) and opioids (−10%) and depressive/mood disorder hospitalizations (−11%) only with increasing slope change in psychostimulant prescribing of (0.9%/month). In contrast to Norway, increasing slope changes occurred in specialist outpatient visits for depressive/mood disorders, eating disorders and schizophrenia/delusional disorders (+1.5, +1.9 and +2.3%/month, respectively). Similar changes occurred in the pre‐existing mental health cohorts.
Conclusion
Differences in early COVID‐19 policy response may have contributed to differences in adult mental healthcare provision in Norway and Sweden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Population Health and Genomics, University of Dundee, Dundee, UK.
- Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.
- School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- PROMENTA Research Center, University of Oslo, Oslo, Norway.
- Department of Pharmacy, Pharmacoepidemiology & Social Pharmacy, Uppsala University, Uppsala, Sweden.
- Pharmacy Center, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
ORCID-Profile: Morten Andersen, Angela Lupattelli, Hedvig Nordeng, Daniel R Morales
Förderung
- NordForsk
- Norges Forskningsråd
- Swedish state
- Swedish Research Council for Health, Working Life and Welfare
- FORMAS
- Wellcome Trust
- Statens geotekniska institut
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
Zitieren
APA
Moreno-Martos, D., Zhao, J., Li, H., Nyberg, F., Bjørndal, L. D., Hajiebrahimi, M., Wettermark, B., Aakjær, M., Andersen, M., Sessa, M., Lupattelli, A., Nordeng, H., & Morales, D. R. (2024). Impact of the early COVID‐19 pandemic on adult mental health‐related dispensed medications, hospitalizations and specialist outpatient visits in Norway and Sweden: Interrupted time series analysis. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16044
Vancouver
Moreno-Martos D, Zhao J, Li H, Nyberg F, Bjørndal LD, Hajiebrahimi M, et al. Impact of the early COVID‐19 pandemic on adult mental health‐related dispensed medications, hospitalizations and specialist outpatient visits in Norway and Sweden: Interrupted time series analysis. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16044
BibTeX
@article{MorenoMartos2024,
author = {Moreno-Martos, David and Zhao, Jing and Li, Huiqi and Nyberg, Fredrik and Bjørndal, Ludvig Daae and Hajiebrahimi, Mohammadhossein and Wettermark, Björn and Aakjær, Mia and Andersen, Morten and Sessa, Maurizio and Lupattelli, Angela and Nordeng, Hedvig and Morales, Daniel R},
title = {Impact of the early COVID‐19 pandemic on adult mental health‐related dispensed medications, hospitalizations and specialist outpatient visits in Norway and Sweden: Interrupted time series analysis},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16044}
}
EUVIMED